PUBLISHER: Grand View Research | PRODUCT CODE: 2152721
PUBLISHER: Grand View Research | PRODUCT CODE: 2152721
Male Infertility Market Size, Share & Trends Analysis Report By Test, By Treatment (Assisted Reproductive Technology & Varicocele Surgery, Medication), By Region, And Segment Forecasts, 2026 - 2033
The global male infertility market size was valued at USD 4.9 billion in 2025 and is projected to grow from USD 5.2 billion in 2026 to USD 8.4 billion in 2033, at a CAGR of 7.1% from 2026 to 2033. Europe dominated the market, accounting for a revenue share of 37.0% in 2025. Increasing infertility rates across the globe and the adoption of assisted reproductive technologies (ARTs) are expected to drive the market for male infertility in the forthcoming years.
ARTs cover a wide spectrum of infertility treatments and offer solutions for males facing problems, such as low sperm count, abnormal sperm quality, and poor motility. Moreover, ARTs offer a higher success rate than medications. The market for male infertility is expected to witness significant growth in the future, owing to technological advancements in the field of assisted reproductive technologies. The integration of artificial intelligence, robotics, and advanced sperm selection technologies into assisted reproductive procedures is improving treatment precision and increasing the likelihood of successful fertilization. For instance, in April 2026, BAIBYS Fertility Ltd. announced the first confirmed pregnancy achieved using its autonomous AI-based robotic sperm selection system for IVF procedures. The technology uses artificial intelligence and robotics to identify and isolate high-quality sperm cells based on morphology and motility, highlighting the increasing integration of advanced technologies into assisted reproductive treatments.
Given the increasing emphasis on early and accurate diagnosis of male infertility, the adoption of advanced semen analysis and sperm quality assessment technologies is expected to grow steadily over the forecast period. Conventional semen analysis remains the primary diagnostic tool for evaluating male reproductive health, while emerging tests provide deeper insights into sperm function and fertility potential. For instance, in April 2026, Legacy launched its Basic Semen Analysis service at a price of USD 145, aiming to improve access to clinical-grade male fertility testing. The company also expanded access to sperm DNA fragmentation testing through its Advanced Semen Analysis offering, enabling a more comprehensive assessment of sperm quality beyond conventional parameters. Such developments are expected to enhance access to male infertility diagnostics, enable earlier intervention, and drive growth in the diagnostic segment.
An increase in the global prevalence of infertility is a significant clinical problem. Around 48 million couples suffer from infertility worldwide. Of all cases, about 20% to 30% of cases are due to male factor infertility. This may be due to one or more factors, such as abnormal morphology, low sperm concentration, and poor sperm motility. Hence, increasing male infertility and growing awareness regarding the same have further prompted the use of drugs, hormonal therapy, and ART. Alcohol intake, smoking, obesity, stress, and lifestyle changes are some of the major factors that can be attributed to infertility in males.
Continuous efforts in R&D are carried out for a better understanding of the idiopathic world of infertility. Hence, companies are investing in developing devices to identify the root cause and enable targeted treatment. Furthermore, the development and commercialization of hormonal therapy are likely to drive the market for male infertility during the forecast period. Governments in various countries have taken initiatives to improve reimbursement for infertility-related treatments. In addition, improved patient data safety resulting from standardized regulations is expected to increase patients' preference for infertility treatments.
Global Male Infertility Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global male infertility market report based on test, treatment, and region:
- Test Outlook (Revenue, USD Billion, 2021 - 2033)
DNA Fragmentation Technique
Oxidative Stress Analysis
Microscopic Examination
Sperm Agglutination
Computer-Assisted Semen Analysis
Sperm Penetration Assay
Others
- Treatment Outlook (Revenue, USD Billion, 2021 - 2033)
Assisted Reproductive Technology and Varicocele Surgery
Medication
- Regional Outlook (Revenue, USD Billion, 2021 - 2033)
North America
- U.S.
- Canada
Europe
- UK
- Germany
- France
- Italy
- Spain
Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
Latin America
- Brazil
- Mexico
- Argentina
Middle East & Africa
- South Africa
- Saudi Arabia
Table of Contents
Chapter 1 Methodology and Scope
- 1.1 Market Segmentation & Scope
- 1.1.1 Test
- 1.1.2 Treatment
- 1.1.3 Regional Scope
- 1.1.4 Estimates and Forecast Timeline
- 1.2 Research Methodology
- 1.3 Information Procurement
- 1.3.1 Purchased Database
- 1.3.2 GVR's Internal Database
- 1.3.3 Secondary Sources
- 1.3.4 Primary research
- 1.4 Information or Data Analysis
- 1.4.1 Data Analysis Models
- 1.5 Market Formulation & Validation
- 1.6 Model Details
- 1.6.1 Commodity flow analysis (Model 1)
- 1.6.2 Volume price analysis (model 2)
- 1.7 List of Secondary Sources
- 1.8 Objectives
- 1.8.1 Objective - 1
- 1.8.2 Objective - 2
Chapter 2 Executive Summary
- 2.1 Market Outlook
- 2.2 Segment Outlook
- 2.2.1 Test
- 2.2.2 Treatment
- 2.2.3 Region
- 2.3 Competitive Insights
- 2.4 Male Infertility Market Outlook, 2021
Chapter 3 Market Variables, Trends & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.2 Market Segmentation
- 3.3 Penetration & Growth Prospect Mapping
- 3.3.1 Penetration Analysis
- 3.3.2 Market driver analysis
- 3.3.2.1 High Adoption of Assisted Reproductive Technology (ART)
- 3.3.2.2 Increasing incidence of infertility
- 3.3.2.3 Acquisitions, mergers, and partnerships in the market
- 3.3.2.4 Technological advancements
- 3.3.3 Market restraint analysis
- 3.3.3.1 High cost of treatment
- 3.4 Male Infertility Market: Business Environment Analysis Tools
- 3.4.1 Porter's Five Forces Analysis
- 3.4.2 PESTEL Analysis
- 3.5 Clinical Trial Analysis
Chapter 4 Male Infertility Market: Test Analysis
- 4.1 Male Infertility Test Market Share Analysis, 2025 & 2033
- 4.2 Male Infertility Test Market: Segment Dashboard:
- 4.3 Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the Test Segment
- 4.3.1 DNA Fragmentation Technique
- 4.3.1.1 DNA fragmentation technique market, 2021 - 2033 (USD Million)
- 4.3.2 Oxidative Stress Analysis
- 4.3.2.1 Oxidative stress analysis market, 2021 - 2033 (USD Million)
- 4.3.3 Microscopic Examination
- 4.3.3.1 Microscopic Examination market, 2021 - 2033 (USD Million)
- 4.3.4 Sperm Agglutination
- 4.3.4.1 Sperm agglutination market, 2021 - 2033 (USD Million)
- 4.3.5 Computer Assisted Semen Analysis
- 4.3.5.1 Computer-assisted semen analysis market, 2021 - 2033 (USD Million)
- 4.3.6 Sperm Penetration Assay
- 4.3.6.1 Sperm penetration assay market, 2021 - 2033 (USD Million)
- 4.3.7 Others
- 4.3.7.1 Others market, 2021 - 2033 (USD Million)
- 4.3.1 DNA Fragmentation Technique
Chapter 5 Male Infertility Market: Treatment Analysis
- 5.1 Male Infertility Treatment Market Share Analysis, 2025 & 2033
- 5.2 Male Infertility Treatment Market: Segment Dashboard:
- 5.3 Market Size & Forecasts and Trend Analyses, 2021 - 2033 for the Treatment Segment
- 5.3.1 ART & Varicocele Surgery
- 5.3.1.1 ART & varicocele surgery market, 2021 - 2033 (USD Million)
- 5.3.2 Medication
- 5.3.2.1 Medication market, 2021 - 2033 (USD Million)
- 5.3.1 ART & Varicocele Surgery
Chapter 6 Male Infertility Market: Regional Analysis
- 6.1 Male Infertility Regional Market Share Analysis, 2025 & 2033
- 6.2 Male Infertility Regional Market: Segment Dashboard
- 6.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
- 6.4 SWOT Analysis, by Region
- 6.4.1 North America
- 6.4.2 Europe
- 6.4.3 Asia Pacific
- 6.4.4 Latin America
- 6.4.5 MEA
- 6.5 Market Size, & Forecasts, and Trend Analysis, 2021 - 2033
- 6.5.1 North America
- 6.5.1.1 North America male infertility market, 2021 - 2033 (USD Million)
- 6.5.1.1.1 U.S.
- 6.5.1.1.1.1 Regulatory & reimbursement scenario
- 6.5.1.1.1.2 U.S. male infertility market, 2021 - 2033 (USD Million)
- 6.5.1.1.2 Canada
- 6.5.1.1.2.1 Regulatory & reimbursement scenario
- 6.5.1.1.2.2 Canada male infertility market, 2021 - 2033 (USD Million)
- 6.5.1.1.1 U.S.
- 6.5.1.1 North America male infertility market, 2021 - 2033 (USD Million)
- 6.5.2 Europe
- 6.5.2.1 Europe male infertility market, 2021 - 2033 (USD Million)
- 6.5.2.1.1 U.K.
- 6.5.2.1.1.1 Regulatory & reimbursement scenario
- 6.5.2.1.1.2 U.K. male infertility market, 2021 - 2033 (USD Million)
- 6.5.2.1.2 Germany
- 6.5.2.1.2.1 Regulatory & reimbursement scenario
- 6.5.2.1.2.2 Germany male infertility market, 2021 - 2033 (USD Million)
- 6.5.2.1.3 France
- 6.5.2.1.3.1 Regulatory & reimbursement scenario
- 6.5.2.1.3.2 France male infertility market, 2021 - 2033 (USD Million)
- 6.5.2.1.4 Italy
- 6.5.2.1.4.1 Regulatory & reimbursement scenario
- 6.5.2.1.4.2 Italy male infertility market, 2021 - 2033 (USD Million)
- 6.5.2.1.5 Spain
- 6.5.2.1.5.1 Regulatory & reimbursement scenario
- 6.5.2.1.5.2 Spain male infertility market, 2021 - 2033 (USD Million)
- 6.5.2.1.1 U.K.
- 6.5.2.1 Europe male infertility market, 2021 - 2033 (USD Million)
- 6.5.3 Asia Pacific
- 6.5.3.1 Asia Pacific male infertility market, 2021 - 2033 (USD Million)
- 6.5.3.1.1 Japan
- 6.5.3.1.1.1 Regulatory & reimbursement scenario
- 6.5.3.1.1.2 Japan male infertility market, 2021 - 2033 (USD Million)
- 6.5.3.1.2 China
- 6.5.3.1.2.1 Regulatory & reimbursement scenario
- 6.5.3.1.2.2 China male infertility market, 2021 - 2033 (USD Million)
- 6.5.3.1.3 India
- 6.5.3.1.3.1 Regulatory & reimbursement scenario
- 6.5.3.1.3.2 India male infertility market, 2021 - 2033 (USD Million)
- 6.5.3.1.4 Australia
- 6.5.3.1.4.1 Regulatory & reimbursement scenario
- 6.5.3.1.4.2 Australia male infertility market, 2021 - 2033 (USD Million)
- 6.5.3.1.5 South Korea
- 6.5.3.1.5.1 Regulatory & reimbursement scenario
- 6.5.3.1.5.2 South Korea male infertility market, 2021 - 2033 (USD Million)
- 6.5.3.1.1 Japan
- 6.5.3.1 Asia Pacific male infertility market, 2021 - 2033 (USD Million)
- 6.5.4 Latin America
- 6.5.4.1 Latin America male infertility market, 2021 - 2033 (USD Million)
- 6.5.4.1.1 Brazil
- 6.5.4.1.1.1 Regulatory & reimbursement scenario
- 6.5.4.1.1.2 Brazil male infertility market, 2021 - 2033 (USD Million)
- 6.5.4.1.2 Mexico
- 6.5.4.1.2.1 Regulatory & reimbursement scenario
- 6.5.4.1.2.2 Mexico male infertility market, 2021 - 2033 (USD Million)
- 6.5.4.1.3 Argentina
- 6.5.4.1.3.1 Regulatory & reimbursement scenario
- 6.5.4.1.3.2 Argentina male infertility market, 2021 - 2033 (USD Million)
- 6.5.4.1.1 Brazil
- 6.5.4.1 Latin America male infertility market, 2021 - 2033 (USD Million)
- 6.5.5 Middle East and Africa (MEA)
- 6.5.5.1 MEA male infertility market, 2021 - 2033 (USD Million)
- 6.5.5.1.1 South Africa
- 6.5.5.1.1.1 Regulatory & reimbursement scenario
- 6.5.5.1.1.2 South Africa male infertility market, 2021 - 2033 (USD Million)
- 6.5.5.1.2 Saudi Arabia
- 6.5.5.1.2.1 Regulatory & reimbursement scenario
- 6.5.5.1.2.2 Saudi Arabia male infertility market, 2021 - 2033 (USD Million)
- 6.5.5.1.3 UAE
- 6.5.5.1.3.1 Regulatory & reimbursement scenario
- 6.5.5.1.3.2 UAE male infertility market, 2021 - 2033 (USD Million)
- 6.5.5.1.1 South Africa
- 6.5.5.1 MEA male infertility market, 2021 - 2033 (USD Million)
- 6.5.1 North America
Chapter 7 Competitive Analysis
- 7.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players)
- 7.2 Vendor Landscape
- 7.2.1 Strategy Mapping
- 7.2.2 Launch of New Products
- 7.2.3 Merger and Acquisition
- 7.2.4 Product Approvals
- 7.3 Company Market Position Analysis (Geographic Presence, Product Portfolio, Strategic Initiatives)
- 7.4 Company Profiles
- 7.4.1 EMD Serono, Inc.
- 7.4.1.1 Company overview
- 7.4.1.2 Financial performance
- 7.4.1.3 Product benchmarking
- 7.4.1.4 Strategic initiatives
- 7.4.2 Endo International plc
- 7.4.2.1 Company overview
- 7.4.2.2 Financial performance
- 7.4.2.3 Product benchmarking
- 7.4.2.4 Strategic initiatives
- 7.4.2.5 SWOT analysis
- 7.4.3 Sanofi
- 7.4.3.1 Company overview
- 7.4.3.2 Financial performance
- 7.4.3.3 Product benchmarking
- 7.4.3.4 Strategic initiatives
- 7.4.3.5 SWOT Analysis
- 7.4.4 Bayer Group
- 7.4.4.1 Company overview
- 7.4.4.2 Financial performance
- 7.4.4.3 Product benchmarking
- 7.4.4.4 Strategic initiatives
- 7.4.4.5 SWOT analysis
- 7.4.5 SCSA Diagnostics
- 7.4.5.1 Company overview
- 7.4.5.2 Product benchmarking
- 7.4.6 Andrology Solutions
- 7.4.6.1 Company overview
- 7.4.6.2 Product benchmarking
- 7.4.7 Halotech DNA SL
- 7.4.7.1 Company overview
- 7.4.7.2 Product benchmarking
- 7.4.7.3 Strategic initiatives
- 7.4.8 Intas Pharmaceuticals Ltd.
- 7.4.8.1 Company overview
- 7.4.8.2 Financial performance
- 7.4.8.3 Product benchmarking
- 7.4.8.4 Strategic initiatives
- 7.4.8.5 SWOT analysis
- 7.4.9 Aytu BioScience, Inc.
- 7.4.9.1 Company overview
- 7.4.9.2 Financial performance
- 7.4.9.3 Product Benchmarking
- 7.4.9.4 Strategic initiatives
- 7.4.9.5 SWOT Analysis
- 7.4.10 Cadila Pharmaceuticals
- 7.4.10.1 Company overview
- 7.4.10.2 Product benchmarking
- 7.4.10.3 Strategic initiatives
- 7.4.11 Vitrolife
- 7.4.11.1 Company overview
- 7.4.11.2 Financial performance
- 7.4.11.3 Product benchmarking
- 7.4.11.4 Strategic initiatives
- 7.4.11.5 SWOT Analysis
- 7.4.1 EMD Serono, Inc.
Chapter 8 Recommendations
List of Tables
- TABLE 1 List of secondary sources
- TABLE 2 North America Male Infertility market, by country, 2021 - 2033 (USD Million)
- TABLE 3 North America Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 4 North America Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 5 U.S. Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 6 U.S. Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 7 Canada Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 8 Canada Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 9 Europe Male Infertility market, by country, 2021 - 2033 (USD Million)
- TABLE 10 Europe Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 11 Europe Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 12 U.K. Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 13 U.K. Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 14 Germany Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 15 Germany Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 16 France Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 17 France Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 18 Italy Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 19 Italy Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 20 Spain Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 21 Spain Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 22 Asia Pacific Male Infertility market, by country, 2021 - 2033 (USD Million)
- TABLE 23 Asia Pacific Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 24 Asia Pacific Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 25 Japan Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 26 Japan Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 27 China Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 28 China Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 29 India Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 30 India Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 31 Australia Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 32 Australia Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 33 South Korea Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 34 South Korea Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 35 Latin America Male Infertility market, by country, 2021 - 2033 (USD Million)
- TABLE 36 Latin America Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 37 Latin America Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 38 Brazil Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 39 Brazil Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 40 Mexico Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 41 Mexico Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 42 Argentina Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 43 Argentina Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 44 MEA Male Infertility market, by country, 2021 - 2033 (USD Million)
- TABLE 45 MEA Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 46 MEA Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 47 South Africa Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 48 South Africa Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 49 Saudi Arabia Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 50 Saudi Arabia Male Infertility market, by treatment, 2021 - 2033 (USD Million)
- TABLE 51 UAE Male Infertility market, by test, 2021 - 2033 (USD Million)
- TABLE 52 UAE Male Infertility market, by treatment, 2021 - 2033 (USD Million)
List of Figures
- FIG. 1 Market research process
- FIG. 2 Information procurement
- FIG. 3 Primary research pattern
- FIG. 4 Market research approaches
- FIG. 5 Value chain based sizing & forecasting
- FIG. 6 QFD modeling for market share assessment
- FIG. 7 Market formulation & validation
- FIG. 8 Male infertility market outlook, 2021 (USD Million)
- FIG. 9 Market trends & outlook
- FIG. 10 Male infertility market segmentation
- FIG. 11 Penetration & growth prospect mapping
- FIG. 12 Market driver relevance analysis (Current & future impact)
- FIG. 13 Market restraint relevance analysis (Current & future impact)
- FIG. 14 Porter's five forces analysis
- FIG. 15 PESTEL analysis
- FIG. 16 Male infertility test market share analysis, 2025 & 2033
- FIG. 17 Male infertility test market: Segment dashboard
- FIG. 18 DNA fragmentation technique market, 2021 - 2033 (USD Million)
- FIG. 19 Oxidative stress analysis market, 2021 - 2033 (USD Million)
- FIG. 20 Microscopic examination market, 2021 - 2033 (USD Million)
- FIG. 21 Sperm agglutination market, 2021 - 2033 (USD Million)
- FIG. 22 Computer assisted semen analysis market, 2021 - 2033 (USD Million)
- FIG. 23 Sperm penetration assay market, 2021 - 2033 (USD Million)
- FIG. 24 Others market, 2021 - 2033 (USD Million)
- FIG. 25 Male infertility treatment market share analysis, 2025 & 2033
- FIG. 26 Male infertility treatment market: Segment dashboard
- FIG. 27 ART & varicocele surgery market, 2021 - 2033 (USD Million)
- FIG. 28 Medication market, 2021 - 2033 (USD Million)
- FIG. 29 Male infertility regional market share analysis, 2025 & 2033
- FIG. 30 Male infertility regional market: Segment dashboard
- FIG. 31 Regional market place: Key takeaways
- FIG. 32 North America male infertility market, 2021 - 2033 (USD Million)
- FIG. 33 U.S. male infertility market, 2021 - 2033 (USD Million)
- FIG. 34 Canada male infertility market, 2021 - 2033 (USD Million)
- FIG. 35 Europe male infertility market, 2021 - 2033 (USD Million)
- FIG. 36 U.K. male infertility market, 2021 - 2033 (USD Million)
- FIG. 37 Germany male infertility market, 2021 - 2033 (USD Million)
- FIG. 38 France male infertility market, 2021 - 2033 (USD Million)
- FIG. 39 Italy male infertility market, 2021 - 2033 (USD Million)
- FIG. 40 Spain male infertility market, 2021 - 2033 (USD Million)
- FIG. 41 Asia Pacific male infertility market, 2021 - 2033 (USD Million)
- FIG. 42 Japan male infertility market, 2021 - 2033 (USD Million)
- FIG. 43 China male infertility market, 2021 - 2033 (USD Million)
- FIG. 44 India male infertility market, 2021 - 2033 (USD Million)
- FIG. 45 Australia male infertility market, 2021 - 2033 (USD Million)
- FIG. 46 South Korea male infertility market, 2021 - 2033 (USD Million)
- FIG. 47 Latin America male infertility market, 2021 - 2033 (USD Million)
- FIG. 48 Brazil male infertility market, 2021 - 2033 (USD Million)
- FIG. 49 Mexico male infertility market, 2021 - 2033 (USD Million)
- FIG. 50 Argentina male infertility market, 2021 - 2033 (USD Million)
- FIG. 51 MEA male infertility market, 2021 - 2033 (USD Million)
- FIG. 52 South Africa male infertility market, 2021 - 2033 (USD Million)
- FIG. 53 Saudi Arabia male infertility market, 2021 - 2033 (USD Million)
- FIG. 54 UAE male infertility market, 2021 - 2033 (USD Million)
- FIG. 55 Recent development & impact analysis
- FIG. 56 Company Categorization
- FIG. 57 Company market position analysis
